2025 年全球智慧切片檢查設備市場報告

預計未來幾年智慧切片檢查設備的市場規模將強勁成長。到 2029 年，這一數字將成長至 40.5 億美元，複合年成長率為 7.5%。預測期內的成長歸因於個人化醫療的成長、影像方式的進步、生物標記分析的切片檢查增加、新參與企業進入市場以及資料連接性的增強。預測期內的主要趨勢包括機器人輔助切片檢查、人工智慧輔助切片檢查、無線切片檢查工具的開發、可攜式手持設備和即時引導系統。

預計未來幾年癌症發生率的上升將推動智慧切片檢查設備市場的成長。癌症涵蓋了各種各樣的疾病，當異常細胞不受控制地生長並擴散到正常邊界之外的其他器官或侵入附近的組織時，幾乎可以發生在身體的任何器官或組織中。癌症患者數量的增加推動了對精準和有針對性的組織樣本的需求。這種需求正在刺激智慧切片檢查設備的開發和增強，該設備具有先進的分子、成像和精確功能，可支援診斷和治療計劃。例如，2024年1月，總部位於瑞士的政府間組織世界衛生組織（WHO）預測，2050年癌症新發病例將超過3500萬例，較2022年記錄的預計2000萬例和970萬例死亡病例增加77%。因此，癌症患者數量的增加正在推動智慧切片檢查市場的成長。

微創技術的採用預計將對智慧切片檢查設備市場的成長做出重大貢獻。微創手術旨在最大限度地減少對身體正常結構的破壞，而智慧切片檢查設備可用於提高組織取樣的精確度和準確度。這些設備通常採用先進的成像技術，例如即時超音波或 MRI 引導，使醫療專業人員能夠透過較小的切口針對特定區域進行切片檢查。這可以減少患者的創傷並提高診斷的準確性。例如，經濟合作暨發展組織2023 年 10 月發布的資料顯示，捷克共和國的白內障手術數量將從 2021 年的 131,612 例增加 8.4%，達到 2022 年的 142,670 例。因此，微創手術的日益普及正在推動要素智慧切片檢查設備市場的發展。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球智慧切片檢查設備PESTEL分析（政治、社會、科技、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球智慧切片檢查設備市場：成長率分析
• 全球智慧切片檢查設備市場表現：規模與成長，2019 年至 2024 年
• 全球智慧切片檢查設備市場預測：2024-2029 年及 2034 年規模與成長
• 全球智慧切片檢查設備總目標市場 (TAM)

第6章 市場細分

• 全球智慧切片檢查設備市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 針切片檢查器械
• 治療托盤
• 本地化線路
• 其他產品
• 全球智慧切片檢查設備市場指導技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 超音波引導下切片切片檢查
• 立體定位切片檢查
• 磁振造影引導切片檢查
• 其他教學方法
• 全球智慧切片檢查設備市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 乳癌
• 皮膚癌
• 肝癌
• 攝護腺癌
• 其他用途
• 全球智慧切片檢查設備市場：按最終用戶、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 學術研究所
• 診斷與影像中心
• 全球智慧切片檢查設備市場，按針式切片檢查儀器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• 芯針切片裝置
• 細針抽吸 (FNA) 裝置
• 真空輔助切片檢查裝置
• 全球智慧切片檢查設備市場、手術托盤細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 預包裝切片檢查程序托盤
• 可客製化治療托盤
• 全球智慧切片檢查設備市場、定位線細分、類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 鉤線定位裝置
• 雷達定位裝置
• 磁定位裝置
• 全球智慧切片檢查設備市場、其他產品細分、按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 切片檢查標記
• 切片檢查成像系統
• 切片檢查引導系統

第7章 區域和國家分析

• 全球智慧切片檢查設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球智慧切片檢查設備市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 智慧切片檢查設備市場：競爭格局
• 智慧切片檢查設備市場：公司簡介
  • Cardinal Health Inc Overview, Products and Services, Strategy and Financial Analysis
  • General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Toshiba Corporation
• Siemens Healthineers
• FUJIFILM Holdings Corporation
• Becton Dickinson and Company
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Olympus Corporation
• Intuitive Surgical Inc.
• Hologic Inc.
• Cook Medical Inc.
• CONMED Corporation
• Leica Biosystems
• Argon Medical Devices Inc.
• Esaote SpA
• SOMATEX Medical Technologies GmbH

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年智慧切片檢查設備市場：提供新機會的國家
• 2029 年智慧切片檢查設備市場：細分市場將帶來新機會
• 智慧切片檢查設備市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

The smart biopsy devices research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including the smart biopsy devices industry's global market size, regional shares, competitors with smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.85 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased cancer cases, demand for minimally invasive procedures, innovations in medical devices, improved diagnostic accuracy

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.

The increasing incidence of cancer is anticipated to drive the growth of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that can occur in nearly any organ or tissue in the body when abnormal cells grow uncontrollably, breach their usual boundaries, and either spread to other organs or invade nearby tissues. The rising number of cancer cases has led to a greater demand for precise and targeted tissue samples. This demand has spurred the development and enhancement of smart biopsy devices featuring advanced molecular, imaging, and precision capabilities to support diagnosis and treatment planning. For example, in January 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that there will be over 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Therefore, the rising number of cancer cases is driving the growth of the smart biopsy device market.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. For instance, data from the Organization for Economic Co-operation and Development in October 2023 revealed an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Major companies in the smart biopsy device market are developing advanced products, such as breast biopsy markers, to enhance the accuracy and effectiveness of breast cancer diagnostics. These markers are specifically designed to accurately identify the location of a tissue sample collected during a biopsy, assisting in future treatments and ensuring that the appropriate area is monitored for potential malignancy. For example, in August 2022, Mammotome, a US-based medical device company, introduced the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy device employs a dual-stage process to deliver precise, high-quality tissue samples and is frequently used with ultrasound guidance to ensure accurate, safe, and efficient breast cancer diagnosis. Additionally, this system can be paired with advanced breast biopsy markers, providing clinicians with a comprehensive and innovative solution for ultrasound-guided breast biopsies.

Major companies in the smart biopsy devices market are introducing new products, such as dual-stage core biopsy instruments, to gain a competitive advantage. Dual-stage core biopsy involves a two-step process, starting with the acquisition stage, where the biopsy instrument is guided to obtain a tissue sample, followed by the extraction stage to retrieve the obtained tissue for diagnostic analysis. For instance, Mammotome, a breast cancer care solutions company, launched the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. This advanced system offers three programmable firing modes and one-handed operation, providing clinicians with a versatile tool for accessing challenging lesions. The system's ergonomic design minimizes needle movements and vibrations, enhancing the overall patient experience.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Needle-Based Biopsy Instruments; Procedure Trays; Localization Wires; Other Products
• 2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
• 3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
• 4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
• Subsegments:
• 1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices; Fine Needle Aspiration (FNA) Devices; Vacuum-Assisted Biopsy Devices
• 2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays; Customizable Procedure Trays
• 3) By Localization Wires: Hook Wire Localization Devices; Radar Localization Devices; Magnetic Localization Devices
• 4) By Other Products: Biopsy Markers; Biopsy Imaging Systems; Biopsy Guidance Systems
• Companies Mentioned: Cardinal Health Inc; General Electric Company; Medtronic Plc; Danaher Corporation; Canon Medical Systems Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Biopsy Devices Market Characteristics

3. Smart Biopsy Devices Market Trends And Strategies

4. Smart Biopsy Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Smart Biopsy Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Smart Biopsy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Smart Biopsy Devices Market Growth Rate Analysis
• 5.4. Global Smart Biopsy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Smart Biopsy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Smart Biopsy Devices Total Addressable Market (TAM)

6. Smart Biopsy Devices Market Segmentation

• 6.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Needle-Based Biopsy Instruments
• Procedure Trays
• Localization Wires
• Other Products
• 6.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• Magnetic Resonance Imaging-Guided Biopsy
• Other Guidance Techniques
• 6.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Skin Cancer
• Liver Cancer
• Prostate Cancer
• Other Applications
• 6.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Academic And Research Institutes
• Diagnostic And Imaging Centers
• 6.5. Global Smart Biopsy Devices Market, Sub-Segmentation Of Needle-Based Biopsy Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Core Needle Biopsy Devices
• Fine Needle Aspiration (FNA) Devices
• Vacuum-Assisted Biopsy Devices
• 6.6. Global Smart Biopsy Devices Market, Sub-Segmentation Of Procedure Trays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Packaged Biopsy Procedure Trays
• Customizable Procedure Trays
• 6.7. Global Smart Biopsy Devices Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hook Wire Localization Devices
• Radar Localization Devices
• Magnetic Localization Devices
• 6.8. Global Smart Biopsy Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopsy Markers
• Biopsy Imaging Systems
• Biopsy Guidance Systems

7. Smart Biopsy Devices Market Regional And Country Analysis

• 7.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Biopsy Devices Market

• 8.1. Asia-Pacific Smart Biopsy Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Biopsy Devices Market

• 9.1. China Smart Biopsy Devices Market Overview
• 9.2. China Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Biopsy Devices Market

• 10.1. India Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Biopsy Devices Market

• 11.1. Japan Smart Biopsy Devices Market Overview
• 11.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Biopsy Devices Market

• 12.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Biopsy Devices Market

• 13.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Biopsy Devices Market

• 14.1. South Korea Smart Biopsy Devices Market Overview
• 14.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Biopsy Devices Market

• 15.1. Western Europe Smart Biopsy Devices Market Overview
• 15.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Biopsy Devices Market

• 16.1. UK Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Biopsy Devices Market

• 17.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Biopsy Devices Market

• 18.1. France Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Biopsy Devices Market

• 19.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Biopsy Devices Market

• 20.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Biopsy Devices Market

• 21.1. Eastern Europe Smart Biopsy Devices Market Overview
• 21.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Biopsy Devices Market

• 22.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Biopsy Devices Market

• 23.1. North America Smart Biopsy Devices Market Overview
• 23.2. North America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Biopsy Devices Market

• 24.1. USA Smart Biopsy Devices Market Overview
• 24.2. USA Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Biopsy Devices Market

• 25.1. Canada Smart Biopsy Devices Market Overview
• 25.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Biopsy Devices Market

• 26.1. South America Smart Biopsy Devices Market Overview
• 26.2. South America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Biopsy Devices Market

• 27.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Biopsy Devices Market

• 28.1. Middle East Smart Biopsy Devices Market Overview
• 28.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Biopsy Devices Market

• 29.1. Africa Smart Biopsy Devices Market Overview
• 29.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

• 30.1. Smart Biopsy Devices Market Competitive Landscape
• 30.2. Smart Biopsy Devices Market Company Profiles
  • 30.2.1. Cardinal Health Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Smart Biopsy Devices Market Other Major And Innovative Companies

• 31.1. Toshiba Corporation
• 31.2. Siemens Healthineers
• 31.3. FUJIFILM Holdings Corporation
• 31.4. Becton Dickinson and Company
• 31.5. Boston Scientific Corporation
• 31.6. B. Braun Melsungen AG
• 31.7. Olympus Corporation
• 31.8. Intuitive Surgical Inc.
• 31.9. Hologic Inc.
• 31.10. Cook Medical Inc.
• 31.11. CONMED Corporation
• 31.12. Leica Biosystems
• 31.13. Argon Medical Devices Inc.
• 31.14. Esaote SpA
• 31.15. SOMATEX Medical Technologies GmbH

32. Global Smart Biopsy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

34. Recent Developments In The Smart Biopsy Devices Market

35. Smart Biopsy Devices Market High Potential Countries, Segments and Strategies

• 35.1 Smart Biopsy Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Smart Biopsy Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Smart Biopsy Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer